BioNTech and Autolus collaborate to expand programs into trials for multiple cancers 08-Feb-2024 By Liza Laws A collaboration to expand autologous CAR-T programs into trials for multiple cancers in a cost-efficient way, has been formed by BioNTech SE and Autolus Therapeutics plc.